Overview

Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the efficacy and safety of the 25mcg vaginal misoprostol for cervical ripening and induction of labour.
Phase:
Phase 3
Details
Lead Sponsor:
Regenex Pharmaceutical, China
Treatments:
Misoprostol